Abstract
Two categories of medications that have soared in popularity in addressing weight loss could eventually become impactful strategies in the treatment of opioid use disorder (OUD) and alcohol use disorder (AUD). But the findings that suggest this potential has been observational to this point, meaning more targeted trials will be necessary before these therapies can be seen as a breakthrough.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
